Lysophosphatidylcholines

"Lysophosphatidylcholines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes one of the fatty acid moieties.

Descriptor ID	D008244
MeSH Number(s)	D10.570.755.375.760.550.550
Concept/Terms	Lysophosphatidylcholines Lysophosphatidylcholines Lysolecithins Lysophosphatidylcholine

Below are MeSH descriptors whose meaning is more general than "Lysophosphatidylcholines".

Chemicals and Drugs [D]
Lipids [D10]
Membrane Lipids [D10.570]
Phospholipids [D10.570.755]
Glycerophosphates [D10.570.755.375]
Phosphatidic Acids [D10.570.755.375.760]
Lysophospholipids [D10.570.755.375.760.550]
Lysophosphatidylcholines [D10.570.755.375.760.550.550]

Below are MeSH descriptors whose meaning is related to "Lysophosphatidylcholines".

Below are MeSH descriptors whose meaning is more specific than "Lysophosphatidylcholines".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lysophosphatidylcholines" by people in this website by year, and whether "Lysophosphatidylcholines" was a major or minor topic of these publications.

Bar chart showing 13 publications over 10 distinct years, with a maximum of 2 publications in 2005 and 2013 and 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
2002	1	0	1
2004	1	0	1
2005	2	0	2
2006	1	0	1
2007	0	1	1
2008	1	0	1
2013	1	1	2
2014	1	1	2
2017	1	0	1

Below are the most recent publications written about "Lysophosphatidylcholines" by people in Profiles.

Wu T, Zheng X, Yang M, Zhao A, Li M, Chen T, Panee J, Jia W, Ji G. Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients. Sci Rep. 2017 02 15; 7:42710.

View in: PubMed
Gazos-Lopes F, Oliveira MM, Hoelz LV, Vieira DP, Marques AF, Nakayasu ES, Gomes MT, Salloum NG, Pascutti PG, Souto-Padr?n T, Monteiro RQ, Lopes AH, Almeida IC. Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi. PLoS Negl Trop Dis. 2014 Aug; 8(8):e3077.

View in: PubMed
Rusielewicz T, Nam J, Damanakis E, John GR, Raine CS, Melendez-Vasquez CV. Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB. Glia. 2014 Apr; 62(4):580-91.

View in: PubMed
Carneiro AB, Iaciura BM, Nohara LL, Lopes CD, Veas EM, Mariano VS, Bozza PT, Lopes UG, Atella GC, Almeida IC, Silva-Neto MA. Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-?B translocation and MAPK/ERK phosphorylation. PLoS One. 2013; 8(9):e76233.

View in: PubMed
Qiu Y, Zhou B, Su M, Baxter S, Zheng X, Zhao X, Yen Y, Jia W. Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients. Int J Mol Sci. 2013 Apr 12; 14(4):8047-61.

View in: PubMed
Mesquita RD, Carneiro AB, Bafica A, Gazos-Lopes F, Takiya CM, Souto-Padron T, Vieira DP, Ferreira-Pereira A, Almeida IC, Figueiredo RT, Porto BN, Bozza MT, Gra?a-Souza AV, Lopes AH, Atella GC, Silva-Neto MA. Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine. Infect Immun. 2008 Dec; 76(12):5543-52.

View in: PubMed
Guo Z, Ran Q, Roberts LJ, Zhou L, Richardson A, Sharan C, Wu D, Yang H. Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice. Free Radic Biol Med. 2008 Feb 01; 44(3):343-52.

View in: PubMed
Zhou L, Shi M, Guo Z, Brisbon W, Hoover R, Yang H. Different cytotoxic injuries induced by lysophosphatidylcholine and 7-ketocholesterol in mouse endothelial cells. Endothelium. 2006 May-Jun; 13(3):213-26.

View in: PubMed
Lee ES, Chen H, Charlton CG, Soliman KF. The role of phospholipid methylation in 1-methyl-4-phenyl-pyridinium ion (MPP+)-induced neurotoxicity in PC12 cells. Neurotoxicology. 2005 Dec; 26(6):945-57.

View in: PubMed
Lee ES, Soliman KF, Charlton CG. Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats. Neurotoxicology. 2005 Jan; 26(1):27-38.

View in: PubMed

People

Explore

Similar Concepts

Top Journals